|
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2).
EC 2.7.11.21 (polo kinase) inhibitor
An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of any polo kinase (EC 2.7.11.21).
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
|
|
|
geroprotector
Any compound that supports healthy aging, slows the biological aging process, or extends lifespan.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
|
|
|
(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide
|
|
(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
|
ChEBI
|
|
2Z-cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
|
ChEBI
|
|
α-cyano-β-hydroxy-β-methyl-N-(2,5-dibromophenyl)propenamide
|
ChEBI
|
|
DDE-28
|
ChEBI
|
